Suchergebnisse - "Daratumumab"

PubPharm (1.488)

11

Adjusted Indirect Treatment Comparison of Progression-Free Survival with D-Rd and VRd Based on MAIA and SWOG S0777 Individual Patient-Level Data

enthalten in: Advances in therapy | 2024

von Durie, B. | Kumar, S. | Ammann, E. | +5

12

Extramedullary relapse of multiple myeloma presenting as space-occupying lesion in liver treated with daratumumab, pomalidomide, dexamethasone and bendamustine

enthalten in: BMJ case reports | 2024

von Wadhera, S. | Jain, A. | Mitra, S. | +1

13

An up-conversion fluorescence lateral-flow immunoassay for rapid detection of Daratumumab in serum protein electrophoresis clinical samples

enthalten in: Clinica chimica acta; international journal of clinical chemistry | 2024

von Liu, Y. | Tao, Y. | Yeung, P. | +5

14

A validated LC-MS/MS method for the quantitation of daratumumab in rat serum using rapid tryptic digestion without IgG purification and reduction

enthalten in: Journal of pharmaceutical and biomedical analysis | 2024

von Li, W. | Huang, W. | Yu, X. | +6

15

CD56 expression predicts response to Daratumumab-based regimens

enthalten in: Blood cancer journal | 2024

von Robinette, A. | Huric, L. | Dona, K. | +2

16

Donor-specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease : A case report

enthalten in: British journal of haematology | 2024

von Kunvarjee, B. | Contreras Yametti, G. | Blouin, A. | +13

17

Efficacy and safety of daratumumab, pomalidomide, and dexamethasone versus daratumumab, carfilzomib, and dexamethasone in daratumumab-naïve relapsed multiple myeloma

enthalten in: European journal of haematology | 2024

von Dima, D. | Mansour, R. | Davis, J. | +9

18

A real‑world pharmacovigilance study of FDA adverse event reporting system events for daratumumab

enthalten in: Expert opinion on drug safety | 2024

von Yun, X. | Zhou, Y. | Wu, D. | +2

19

Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation : Dutch real-world data

enthalten in: Blood advances | 2024

von Weverling, F. | Roeven, M. | Nijssen, C. | +12

20

At what point are we on the way to optimally treat multiple myeloma patients over 75 years of age in 2023?

enthalten in: Advances in clinical and experimental medicine : official organ Wroclaw Medical University | 2024

von Tyczyńska, A. | Zaucha, J.